via ACS
Going to the doctor might make you want to cry, and according to a new study, doctors could someday put those tears to good use.
In ACS Nano, researchers report a nanomembrane system that harvests and purifies tiny blobs called exosomes from tears, allowing researchers to quickly analyze them for disease biomarkers. Dubbed iTEARS, the platform could enable more efficient and less invasive molecular diagnoses for many diseases and conditions, without relying solely on symptoms.
Diagnosing diseases often hinges on assessing a patient’s symptoms, which can be unobservable at early stages, or unreliably reported. Identifying molecular clues in samples from patients, such as specific proteins or genes from vesicular structures called exosomes, could improve the accuracy of diagnoses. However, current methods for isolating exosomes from these samples require long, complicated processing steps or large sample volumes. Tears are well-suited for sample collection because the fluid can be collected quickly and non-invasively, though only tiny amounts can be harvested at a time. So, Luke Lee, Fei Liu and colleagues wondered if a nanomembrane system, which they originally developed for isolating exosomes from urine and plasma, could allow them to quickly obtain these vesicles from tears and then analyze them for disease biomarkers.
The team modified their original system to handle the low volume of tears. The new system, called “Incorporated Tear Exosomes Analysis via Rapid-isolation System” (iTEARS), separated out exosomes in just 5 minutes by filtering tear solutions over nanoporous membranes with an oscillating pressure flow to reduce clogging. Proteins from the exosomes could be tagged with fluorescent probes while they were still on the device and then transferred to other instruments for further analysis. Nucleic acids were also extracted from the exosomes and analyzed. The researchers successfully distinguished between healthy controls and patients with various types of dry eye disease based on a proteomic assessment of extracted proteins. Similarly, iTEARS enabled researchers to observe differences in microRNAs between patients with diabetic retinopathy and those that didn’t have the eye condition, suggesting that the system could help track disease progression. The team says that this work could lead to a more sensitive, faster and less invasive molecular diagnosis of various diseases — using only tears.
Original Article: ‘iTEARS’ could help diagnose diseases by isolating biomarkers in tears
More from: Wenzhou Medical University | American Chemical Society
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
Biomarkers in tears
- Biomarkers identified for successful treatment of bone marrow tumors
CAR T cell therapy has proven effective in treating various hematological cancers. However, not all patients respond equally well to treatment. In a clinical study, researchers from the University of ...
- Biomarkers Supporting Drug Approvals Lack Strong Supporting Data, Study Says
Investigators found that the FDA OK’d nearly 80 percent of these non-supported surrogate markers as appropriate endpoints for a traditional approval.
- Biophysics: Testing how well biomarkers work
Jungmann's team has now presented a technique in the journal Nature Methods that can be used to quantify how well biomarker molecules bind to the target proteins. "This is absolutely crucial if you ...
- Testing how well biomarkers work
The method developed by Jungmann’s team makes this assessment possible by adding a reference biomarker to the target proteins. This marker “glows” in a different color during microscopy, so that ...
- Detecting cancer in minutes possible with just a drop of dried blood and new test, study hints
Early tests suggest that a new tool that requires only a single drop of blood could detect three of the deadliest forms of cancer.
Go deeper with Google Headlines on:
Biomarkers in tears
[google_news title=”” keyword=”biomarkers in tears” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]
Go deeper with Bing News on:
Molecular diagnosis
- Prevalence Of Infectious Diseases Drives The Molecular Quality Controls Market Growth
Moreover, increased support from the governments to control the outbreaks of infectious diseases and a rise in the demand for quality control support along with immediate molecular diagnosis systems ...
- Machine learning system offers new hope for diagnosis of rare genetic disorders
There is an urgent need for new approaches to enhance the speed and accuracy of diagnosis," said co-corresponding author Dr. Pengfei Liu, associate professor of molecular and human genetics and ...
- AI-MARRVEL: New AI Accelerates Diagnosis of Rare Genetic Disorders
AIM, developed by Baylor College of Medicine, enhances genetic diagnosis accuracy and speed by prioritizing causative variants in rare diseases, showing superior results compared to other methods.
- Vietnam PoC Molecular Diagnostic Market Future Ascent Market Size’s Journey to Unseen Heights
Report Ocean’s latest analysis delves into the “Vietnam PoC Molecular Diagnostic Market” Report from 2024 to 2032, covering an array of market facets such as characteristics, size, growth, ...
- Vietnam Molecular Diagnostic Market Upcoming Peaks Market Size’s Projection to Reach New Heights
Report Ocean’s latest analysis delves into the “Vietnam Molecular Diagnostic Market” Report from 2024 to 2032, covering an array of market facets such as characteristics, size, growth, segmentation, ...
Go deeper with Google Headlines on:
Molecular diagnosis
[google_news title=”” keyword=”molecular diagnosis” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]